Figure 3. The placebome module genes and significance of their SNPs in modifying the outcome (total cardiovascular disease [CVD] and major CVD incidence) in age- and fully adjusted Cox proportional hazards models of outcomes in the placebo arm of the Women’s Genome Health Study (WGHS).

Fully adjusted models were adjusted for age, blood pressure, cholesterols, triglycerides, and family history of diabetes mellitus and myocardial infarction.